| 11/13/2025 12:00 |
CONSOLIDATED FINANCIAL SUMMARY 2Q FY 2025 (from April, 2025 to September, 2025) |
| 11/13/2025 12:00 |
Notice Concerning Disposal of Treasury Shares Through Third-party Allotment Associated with Additional Contribution to the BBT and the J-ESOP |
| 11/13/2025 12:00 |
Financial results Presentation For 6-month Period Ended September 30, 2025 |
| 11/13/2025 12:00 |
Notice of Revision of the Financial Results Forecast,Payment of a Dividend of Surplus (Interim Dividend), and Revision of the Dividend Forecast |
| 10/21/2025 10:00 |
Announcement Concerning the Presentation of Results from the Domestic Phase 2 Clinical Trial at ESMO Congress 2025 |
| 10/01/2025 10:15 |
Announcement of Completion of the Specified Clinical Research of BNCT for Recurrent Breast Cancer, with the Cooperation of CICS |
| 08/13/2025 12:00 |
CONSOLIDATED FINANCIAL SUMMARY 1Q FY 2025 (from April 1, 2025 to June 30, 2025) |
| 08/13/2025 12:00 |
Financial results Presentation For 3-month Period Ended June 30, 2025 |
| 07/28/2025 12:00 |
CICS, Inc. has achieved the primary endpoint in a domestic phase2 clinical trial of BNCT for the treatment of angiosarcoma |
| 07/25/2025 16:30 |
Notice Concerning Completion of Allotment of Treasury Shares Disposed as Restricted Share Compensation |
| 07/07/2025 18:20 |
Corporate Governance Report |
| 07/07/2025 17:20 |
Corporate Governance Report |
| 06/27/2025 18:15 |
Corporate Governance Report |
| 06/26/2025 16:00 |
Notice Concerning Disposal of Treasury Shares as Restricted Share Compensation |
| 06/26/2025 16:00 |
Notice of Organizational Changes, Personnel Changes of Directors,Executive Officers and Personnel Changes |
| 06/03/2025 08:00 |
Notice of Convocation Annual General Meeting 2025 |
| 05/19/2025 14:00 |
[Updated]CONSOLIDATED FINANCIAL SUMMARY FY2024 (from April 1, 2024 to March 31, 2025) |
| 05/15/2025 15:40 |
Financial results Presentation For the year Ended March 31, 2025 |
| 05/15/2025 15:40 |
CONSOLIDATED FINANCIAL SUMMARY FY2024 (from April 1, 2024 to March 31, 2025) |
| 05/15/2025 15:40 |
Announcement Regarding Dividend from Retained Earnings (Dividend Increase) |
| 02/14/2025 12:00 |
Financial results Presentation For 9-month Period Ended December 31, 2024 |
| 02/14/2025 12:00 |
Notice Concerning Revision of Earnings and Dividend Forecast |
| 02/14/2025 12:00 |
CONSOLIDATED FINANCIAL SUMMARY 3Q FY 2024 (from April 1, 2024 to December 31, 2024) |
| 01/16/2025 16:00 |
Notice Concerning Stock Split and Associated Partial Amendment of Articles of Incorporation and Partial Change to Shareholder Benefit Plan |
| 12/19/2024 17:00 |
Corporate Governance Report |
